Friday, October 12, 2012

Big Pharma in expectation of big backs!

Drugs often fail to live up to blockbuster expectations, of course. Physicians and patients turn out to be less enthusiastic than expected, or another therapy comes along that disrupts everything much faster than anticipated. Drug development is long and hard, and it's not always easy to gauge what the future holds.
1 T-DM1
2 BG-12
3 Darapladib
4 Gantenerumab
5 GS-7977
6 REGN727
7 Odanacatib
8 Anacetrapib
9 Eliquis (apixaban)
10 Tofacitinib
11 Bardoxolone
12 Lu AA21004/vortioxetine
13 QVA149
14 Macitentan
15 Alpharadin

No comments:

Post a Comment